Abstract:5-methylcytosine (5mC) is the most common chemical modification occurring on the CpG sites across the human genome. Bisulfite conversion combined with short-read whole genome sequencing can capture and quantify the modification at single nucleotide resolution. However, the PCR amplification process could lead to duplicative methylation patterns and introduce 5mC detection bias. Additionally, the limited read length also restricts co-methylation analysis between distant CpG sites. The bisulfite conversion process presents a significant challenge for detecting variant-specific methylation due to the destruction of allele information in the sequencing reads. To address these issues, we sought to characterize the human methylation profiling with the nanopore long-read sequencing, aiming to demonstrate its potential for long-range co-methylation analysis with native modification call and intact allele information retained. In this regard, we first analyzed the nanopore demo data in the adaptive sampling sequencing run targeting all human CpG islands. We applied the linkage disequilibrium (LD) R2 to calculate the co-methylation in nanopore data, and further identified 27,875, 50,481, 26,542 and 51,189 methylation haplotype blocks (MHB) in COLO829, COLO829BL, HCC1395 and HCC1395BL cell lines, respectively. Interestingly, while we found that majority of the co-methylation were in a short range (≤200bp), a small portion (1~3%) showed long distance (≥1,000bp), suggesting potential remote regulatory mechanisms across the genome. To further characterize the epigenetic changes related to transcription factor binding, we profiled the 5mC percentage changes surrounding various motif sites in JASPAR collection and found that CTCF and KLF5 binding sites showed reduced methylation, while FOXE1 and ZNF354A sites showed increased methylation. To further investigate the allele-specific 5mCG in the prostate genome, we designed a target region covering methylation quantitative trait loci (mQTL) and genome-wide association study (GWAS) risk germline variants and generated long reads with adaptive sampling run in the 22Rv1 cell line. To identify the allele-specific methylation in the 22Rv1 cell line, we performed long-read based phasing and compared the 5mCG signals between the two haplotypes. As a result, we identified 6,390 haplotype-specific methylated regions in the 22Rv1 cell line (p-MWU ≤ 1e-5 and delta ≥ 50%). By examining haplotype-specific methylated regions near the phasing variants, we identified examples of allele-specific methylated regions that showed allele-specific accessibility in the ATAC-seq data. By further integrating the ATAC-seq data of 22Rv1, we found that methylation levels were negatively correlated with chromatin accessibility at the genome-wide scale. Our study has revealed native methylome profiling while preserving haplotype information, offering a novel approach to uncovering the regulatory mechanisms of the human prostate genome.

Characterization of DNA Methylation in Short Tandem Repeats in Human Genome

Characterization of genome-wide STR variation in 6487 human genomes

Methylation Status of the Long Control Region of Hpv 16 in Clinical Cervical Specimens

Identification of DNA Motifs That Regulate DNA Methylation.

Investigating the Relationship of Dna Methylation with Mutation Rate and Allele Frequency in the Human Genome

Evaluating methylation of human ribosomal DNA at each CpG site reveals its utility for cancer detection using cell-free DNA

Fine Mapping Regulatory Variants by Characterizing Native CpG Methylation with Nanopore Long Read Sequencing

DNA methylation-environment interactions in the human genome

Characterization of Genome-Methylome Interactions in 22 Nuclear Pedigrees

Genome-wide quantification of the effects of DNA methylation on human gene regulation

Correlation Between MDR1 Methylation Status in the Promoter Region and MDR1 Genetic Polymorphism in 194 Healthy Chinese Han Subjects

The DNA Methylome of Human Peripheral Blood Mononuclear Cells.

DNA methylation marker identification and poly-methylation risk score in prediction of healthspan termination

Characterizing the Strand-Specific Distribution of Non-Cpg Methylation in Human Pluripotent Cells.

The Identification of Specific Methylation Patterns across Different Cancers

Dynamic DNA methylation across diverse human cell lines and tissues

DNA Methylome Profiling at Single-Base Resolution Through Bisulfite Sequencing of 5Mc-Immunoprecipitated DNA.

Identification of cancer DNA methylation regulatory sites

Characterization of the DNA methylome and its interindividual variation in human peripheral blood monocytes.

GeMes, clusters of DNA methylation under genetic control, can inform genetic and epigenetic analysis of disease.

Genome-wide Methylation Analysis of Prostate Tissues Reveals Global Methylation Patterns of Prostate Cancer.